Sequoia Financial Advisors’s Cellectar Biosciences CLRB Stock Holding History

Sequoia Financial Advisors’s Portfolio CLRB Stock Details CLRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.7K	Buy	21,850 +3,000	+16%	+$8.39K	﹤0.01%	2116
2026 Q1	$47.9K	Sell	18,850 -6,500	-26%	-$21K	﹤0.01%	1891
2025 Q4	$74.8K	Buy	25,350 +14,567	+135%	+$53.8K	﹤0.01%	1886
2025 Q3	$60.4K	Buy	+10,783	New	+$53.4K	﹤0.01%	1712
2025 Q2	–	Sell	-6,775	Closed	-$64.1K	–	1597
2025 Q1	$64.1K	Buy	6,775 +6,292	+1,303%	+$57K	﹤0.01%	1342
2024 Q4	$4.34K	Sell	483 -310	-39%	-$14.3K	﹤0.01%	1345
2024 Q3	$50.9K	Buy	+793	New	+$52.3K	﹤0.01%	1253

Other funds holding CLRB

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sequoia Financial Advisors's CLRB Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Cellectar Biosciences (CLRB) stake by 16% in Q2 2026, buying an estimated $8.39K and bringing the position to 21,850 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Sequoia Financial Advisors first reported a position in CLRB in Q3 2024 and has held it in 7 quarters since. The position peaked at $74.8K in Q4 2025. 2 funds tracked by Wall St. Rank hold CLRB as of Q2 2026.

Sequoia Financial Advisors held 21,850 shares of Cellectar Biosciences worth $60.7K as of Q2 2026.
Sequoia Financial Advisors bought 3,000 Cellectar Biosciences shares in Q2 2026, an estimated $8.39K.
Cellectar Biosciences made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2116 holding.
Sequoia Financial Advisors first reported a position in Cellectar Biosciences in Q3 2024 and has held it in 7 quarters since.
Sequoia Financial Advisors's Cellectar Biosciences position peaked at $74.8K in Q4 2025.
2 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.